secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aprea Therapeutics, Inc. (APRE)
CIK:        0001781983
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001558370-25-000155
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aprea Therapeutics reports Dec 31, 2024 cash balance of $22.8M
--------------------------------------------------------------

- Cash and cash equivalents of $22.8M as of December 31, 2024 (preliminary, unaudited).
- Disclosed via corporate presentation posted to company website on January 13, 2025.
- Balance subject to completion of fiscal 2024 year-end financial statements.
- No other financial results or guidance provided in the presentation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781983/000155837025000155/0001558370-25-000155-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781983/000155837025000155/apre-20250113x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-000155

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer